arrow
K

Keiko Suzuki

astellas pharmaceuticals
H指数:28
被引数:3,563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced Neuropathy

奥沙利铂诱导的神经病变损伤了周围毛细血管中的内皮糖萼

2024-06-010
OAAI
Investigation of the relationship between intradialytic hypotension during hemodialysis and serum syndecan-1 concentration
2023-10-050
OAAI
Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemia

重组血栓调节蛋白可能通过促进Glypican-1表达保护实验性内毒素血症下的心脏毛细血管内皮糖萼

HELIYON
IF3.6
2022-11-016
OAAI
Syndecan-1 as a severity biomarker for patients with trauma

Syndecan-1作为创伤患者严重程度的生物标志物

2022-09-2714
OAAI
Measuring the Concentration of Serum Syndecan-1 to Assess Vascular Endothelial Glycocalyx Injury During Hemodialysis
2021-12-2311
OAAI
Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination

提高血清Syndecan-1浓度的因素: 大规模综合医学检查

2019-08-2725
OAAI
Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation
2015-03-0692
OAAI